FDA approves new treatment for metastatic breast cancers
The U.S. Food and Drug Administration Thursday approved Verzenio to treat adult patients with HR positive and HER2 negative metastatic breast cancer.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | HER2